Panel discussion 'Right to Try'
13:30 - 14:00 | Rotterdam Hall
Societal changes and digital innovation have led to growing patient empowerment in healthcare. In the U.S. ‘Right-to-try’ laws have even been created to give terminally ill patients access to novel drugs that are not yet approved by the FDA, but are likely to save their lives.
What are the pros and cons of giving patients early access to experimental drugs? Should patients have extra options beyond what is currently available via compassionate use?
During this panel session we will discuss this topic with stakeholders from different perspectives.
Maurits van Selms
ALS patient & ACTA
Ton de Boer
Medicine Evaluation Board
Ingmar de Gooijer
Reboocon has won the AXON Innovation for Health Award 2019 for the best start-up pitch at the sixth edition of Innovation for Health and the third edition of Global Investor Forum in WTC Rotterdam on 14 February 2019. Reboocon competed against River Biomedics in the plenary afternoon programme and at the end received the majority vote from the audience as the best start-up.
Read press release
The teaser of Innovation for Health 2019 is online now, including highlights of keynote speakers, sessions and themes.
Watch the new teaser film of Innovation for Health to get an impression of what you can expect.
Like what you see? We hope to welcome you on 14 February!
Watch the teaser
Did you enjoy Innovation for Health & Global Investor Forum 2019?
Take a look at our photo impression and you will experience the event of 14 February all over again!
Go to Photo Impression
© 2019 Innovation for Health